A snapshot of evolving practice
As one of a limited number of cardiothoracic surgery programs that offer esophageal procedures, Cleveland Clinic’s Department of Thoracic and Cardiovascular Surgery has seen its esophageal surgery volumes rise in recent years, surging to 261 cases in 2016.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Esophagectomy for esophageal cancer is one procedure where volume-based expertise is yielding the greatest outcome dividends: Across 153 esophagectomies from July 2013 through June 2016, Cleveland Clinic surgeons achieved among the lowest risk-adjusted combined morbidity and 30-day mortality rates in the entire country, with a standardized incidence ratio of 0.55 (95% CI, 0.38-0.75), according to the Society of Thoracic Surgeons General Thoracic Surgery Database.
Now Cleveland Clinic surgeons are increasingly turning to robotics to offer a minimally invasive option to patients requiring esophagectomy. A snapshot of robotic esophagectomy is presented above, showing engagement of an end-to-end anastomosis stapler to connect the gastric conduit with the proximal esophagus.
“Minimally invasive esophagectomy is a complex operation and requires a multidisciplinary approach and very careful patient selection,” says Sudish Murthy, MD, PhD, Section Head of Thoracic Surgery.
“The best way to achieve excellent results after esophagectomy is to tailor the operation for the patient and his or her cancer,” adds Siva Raja, MD, PhD, Surgical Director, Center for Esophageal Disorders. “We are facile in performing all the variations of esophagectomy, even in the setting of chemotherapy and radiation, to help our patients achieve their cure.”
Advertisement
Advertisement
3 specialists share multidisciplinary perspectives on a widely impactful cardiovascular condition
Experience-based takes on valve-sparing root replacement from two expert surgeons
Two surgeons share insights on weighing considerations across the lifespan
Join us in Florida this winter for a long-standing CME favorite
BITA grafts themselves are rarely to blame, and outcomes can be good
First-in-human phase 1 trial induced loss of function in gene that codes for ANGPTL3
Cleveland Clinic report shares details and outcomes of novel technique for open repair
Two cardiac surgeons explain Cleveland Clinic’s philosophy of maximizing arterial graft use